AU Stock MarketDetailed Quotes

IMM Immutep Ltd

Watchlist
  • 0.302
  • +0.007+2.37%
20min DelayTrading Mar 19 15:14 AET
439.59MMarket Cap-8.39P/E (Static)

Immutep Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Immutep Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/H2-- / 3.200M--
--2025/H17.276M / 2.150M--
--2024/H23.728M / 2.000M--
--2024/H14.110M / 2.100M--
--2023/H22.617M / 3.233M--
DatePeriodRevenue/EstimateEarnings Call
--2025/H2-- / 3.200M--
--2025/H17.276M / 2.150M--
--2024/H23.728M / 2.000M--
--2024/H14.110M / 2.100M--
--2023/H22.617M / 3.233M--

Unlock Free Earnings Estimates

Immutep Ltd Earnings Reports

  • Immutep Ltd: Half Yearly Report and Accounts

    Feb 26 02:58 ET

  • Immutep Ltd: Immutep Investor Update

    Nov 25, 2024 21:42 ET

  • Immutep Ltd: Annual Report filed on Form 20-F with SEC

    Oct 22, 2024 17:23 ET

  • Immutep Ltd: Annual Report to shareholders

    Oct 21, 2024 21:03 ET

    • Read more

    Trending Stocks
    ASX High Dividend ASX High Dividend
    Symbol Div YieldTTM Dividend TTM
    Telstra Group Ltd
    TLS
    4.26% 0.18
    Westpac Banking Corp
    WBC
    4.87% 1.47
    National Australia Bank Ltd
    NAB
    5.15% 1.68
    BHP Group Ltd
    BHP
    6.03% 2.39
    Woodside Energy Group Ltd
    WDS
    9.10% 2.08

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 27, 2025

    Strong Buy

    • Strong Buy

      80.00%

    • Buy

      20.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Healthcare - Cancer Research
    Healthcare - Cancer Research
    Intraday+0.85%